A detailed history of Teacher Retirement System Of Texas transactions in Abb Vie Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 465,124 shares of ABBV stock, worth $90 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
465,124
Previous 475,014 2.08%
Holding current value
$90 Million
Previous $86.5 Million 7.77%
% of portfolio
0.45%
Previous 0.55%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $1.53 Million - $1.79 Million
-9,890 Reduced 2.08%
465,124 $79.8 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $369,823 - $421,379
-2,314 Reduced 0.48%
475,014 $86.5 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $12.3 Million - $13.9 Million
-89,408 Reduced 15.78%
477,328 $74 Million
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $7.99 Million - $9.26 Million
59,846 Added 11.81%
566,736 $84.5 Million
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $4.14 Million - $5.16 Million
-31,276 Reduced 5.81%
506,890 $68.3 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $1.94 Million - $2.24 Million
-13,438 Reduced 2.44%
538,166 $85.8 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $20.1 Million - $24.1 Million
-145,593 Reduced 20.88%
551,604 $89.1 Million
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $6.51 Million - $7.47 Million
-48,533 Reduced 6.51%
697,197 $93.6 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $16.5 Million - $21 Million
119,879 Added 19.15%
745,730 $114 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $8.7 Million - $10.8 Million
65,907 Added 11.77%
625,851 $101 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $12 Million - $15.2 Million
111,845 Added 24.96%
559,944 $75.8 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $17.1 Million - $19.4 Million
-160,681 Reduced 26.39%
448,099 $48.3 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $55.7 Million - $62.1 Million
-529,733 Reduced 46.53%
608,780 $68.6 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $10.6 Million - $11.6 Million
-103,409 Reduced 8.33%
1,138,513 $123 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $21.9 Million - $29.5 Million
271,525 Added 27.98%
1,241,922 $133 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $16.7 Million - $19.6 Million
194,210 Added 25.02%
970,397 $85 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $24.1 Million - $32.3 Million
328,709 Added 73.46%
776,187 $76.2 Million
Q1 2020

May 05, 2020

SELL
$64.5 - $97.79 $6.99 Million - $10.6 Million
-108,307 Reduced 19.49%
447,478 $34.1 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $5.22 Million - $6.53 Million
72,327 Added 14.96%
555,785 $49.2 Million
Q3 2019

Oct 28, 2019

SELL
$62.98 - $75.72 $3.41 Million - $4.1 Million
-54,181 Reduced 10.08%
483,458 $36.6 Million
Q2 2019

Aug 05, 2019

SELL
$65.7 - $83.98 $19 Million - $24.3 Million
-289,422 Reduced 34.99%
537,639 $39.1 Million
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $1.02 Million - $1.19 Million
-13,160 Reduced 1.57%
827,061 $66.7 Million
Q4 2018

Mar 04, 2019

SELL
$77.85 - $96.01 $17.7 Million - $21.8 Million
-227,002 Reduced 21.27%
840,221 $77.5 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $15.2 Million - $16.9 Million
-170,514 Reduced 13.78%
1,067,223 $101 Million
Q2 2018

Aug 06, 2018

BUY
$89.78 - $106.23 $34 Million - $40.2 Million
378,510 Added 44.05%
1,237,737 $115 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $1.18 Million - $1.59 Million
-12,878 Reduced 1.48%
859,227 $81.3 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $45.5 Million - $49.9 Million
-508,541 Reduced 36.83%
872,105 $84.3 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $96.4 Million - $123 Million
1,380,646
1,380,646 $123 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.